While still in it’s development stage, HHS and the FDA are releasing the below Safe Importation Action Plan to describe steps that will be taken to allow the importation of certain drugs from Canada, as well as allow manufacturers to import versions of drugs they sell in foreign countries that are the same as US versions, potentially allowing them to offer a lower price that what current distribution contracts allow.
There are outlines specific to eligible and non-eligible drugs on page 2. This is not the final proposal, and future adjustments may occur.
It is a promising development in the continued struggle for affordable RX therapies in the US. Contact your NEEBCo representative with questions.